Streptococcus agalactiae is an important pathogen in neonatal sepsis, late-onset meningitis in infants, postpartum endometritis, and infections in immunocompromised adults (28) . The role of bacterial proteins as virulence determinants in the pathogenesis of infections with group B streptococci (GBS) is not well defined. In 1969, Wilkinson and Moody first identified unique protein antigens in some strains of GBS (40) . Lancefield et al. showed that antibodies raised to these GBS surface proteins (called C proteins) provided passive protection to mice challenged with GBS; this passive protection did not extend to non-C-protein-bearing strains (25) . Therefore, the C proteins have been defined by their biological activity, the ability to elicit protective antibodies (15, 20) . C proteins were subsequently found on all serotype Ib and many type Ia and II GBS, but they are uncommon on type III GBS (5, 23) .
C proteins have been extracted from the surface of GBS with hot hydrochloric acid (7), nonionic detergents (36) , and the enzyme mutanolysin (27) . In addition, C proteins have been identified in culture supernatants (38) . The molecular sizes reported have varied from 14,000 to several hundred thousand daltons (29) . None of the C proteins have been purified to homogeneity, and the number and biological functions of these proteins are not known.
Some immunological and biochemical properties of the antigenic determinants corresponding to two C proteins have been described. The alpha antigen is resistant to the protease trypsin and does not bind immunoglobulins (8, 39) . The beta antigen is sensitive to both trypsin and pepsin and binds to the Fc portion of human immunoglobulin A (IgA) (14, 35) . * Corresponding author.
Two additional potential C protein antigens, gamma and delta, have been described but not characterized biochemically (11) . Two presumptive C-protein clones have been reported (13) , and earlier work characterizing the C proteins has recently been reviewed (29) .
We have previously shown that polyclonal antisera raised to surface proteins of GBS following mutanolysin extraction provide protective immunity in a mouse lethality model (27) . In this article we describe the use of these protective antisera to screen a recombinant library of DNA fragments from GBS strain A909 cloned in a specially constructed plasmid expression vector. We have identified and characterized two groups of clones that encode and express the C-protein alpha and beta antigens in Escherichia coli. It is of note that antisera raised against each of these groups of clones provided protective immunity to GBS infection in the mouse lethality model. There is no immunological cross-reactivity between the cloned antigens, and Southern blot hybridization shows no homology between the clones. Therefore, we have cloned and characterized two unique and protective surface-associated C-protein antigens from GBS.
Genetic characterization of these clones should make it possible to define the role of the C-protein antigens in the pathogenesis of GBS infections. In addition, the protective C-protein epitopes expressed by these clones may be useful in the development of a conjugate vaccine against GBS (3).
MATERIALS AND METHODS
Bacterial strains, plasmids, transposons, and media. GBS strains A909 (Ia/C), H36B (lb/C) (from R. Lancefield), and 515 (Ia) are part of the Channing Laboratory collection (25) . Plasmid pUC12, transposon TnS, and E. coli MC1061 (supE) and DK1 (lacks recA) are from the collection in the Department of Molecular Biology (2), and strain pCNB was obtained from S. Calderwood (26) , both at Massachusetts General Hospital. The transposon TnSSeql is from D. Berg (31) , and E. coli NK-8032 is from N. Kleckner (2). pUX12 is described in this study. GBS were grown on Todd-Hewitt broth (Difco). E. coli strains were grown on Luria-Bertani broth and agar (1.5%) (Gibco/Bethesda Research Laboratories). Antibiotics (Sigma) were added to a final concentration of 100 jig/ml for ampicillin and kanamycin. DNA procedures. Standard procedures for the preparation of plasmid DNA, restriction endonuclease mapping, agarose gel electrophoresis, and Southern blot hybridization are from Ausubel et al. (2) . Genomic DNA from GBS was isolated by the method of Hull et al. (22) as modified by Rubens et al. (34) . Transposon mutagenesis was done with both TnS and TnSSeql, as described previously (2, 30) .
Modification of pUC12 to pUX12. The plasmid vector pUX12 was developed for screening expression of cloned bacterial chromosomal DNA. Plasmid pUC12 is a 2.73-kb, high-copy-number plasmid that carries a ColEl origin of replication, ampicillin resistance, and a polylinker in the lacZ gene. The overall strategy for modifying pUC12 was to modify the polylinker by adding identical but noncohesive BstXI sites for cloning, to add a cassette to allow easy separation of the linear host plasmid, and to provide for expression from the lacZ promoter in all three translational reading frames. The addition of the BstXI sites and cassette fragment has been reported previously (1) .
To construct a + 1 reading frame, pUX12 was cut with EcoRI, which cleaves at a unique site in the polylinker. The single-stranded 5' sticky ends were filled in by using the 5'->3' polymerase activity of T4 DNA polymerase, and the two blunt ends were ligated. This procedure resulted in the loss of the EcoRI site and the creation of a new XmnI site. To construct a -1 reading frame, pUX12 was cut with Sacl, which cleaves at a unique site in the polylinker. The singlestranded 3' sticky ends were cut back to blunt ends by using the 3'-*5' exonuclease activity of T4 polymerase, and the resulting blunt ends were ligated. The +1 reading frame, called pUX12+1, was confirmed by restriction mapping and double-stranded DNA sequencing of the polylinker. DNA sequencing of the -1 reading frame, called pUX12-1, showed that 10 nucleotides were absent from the wild-type pUX12, a result suggesting that T4 DNA polymerase had additional exonuclease activity but confirming the presence of a -1 reading frame.
Cesium chloride-purified genomic DNA from A909 was partially restricted with four endonucleases: AluI, FnuDII, HaeIII, and RsaI. The restriction fragments were ligated to two synthetic oligomers, ACACGAGATTTC and CTCTA AAG. The resulting DNA fragments with BstXI ends were separated from unincorporated oligomers on a potassium acetate velocity gradient. The plasmids pUX12, pUX12+1, and pUX12-1 were mixed in equal proportions and cut with BstXI. The cassette in the polylinker was removed from the plasmid by a low-melting-point agarose gel. The genomic GBS DNA fragments with BstXI ends were ligated to the mixture of linear pUX12 plasmids, thereby allowing GBS DNA ligated into the polylinker of the pUX12 vector to be excised via BamHI sites contained within the BstXI oligonucleotide adapters.
Isolation of clones and screening for expression. The pUX12 plasmid library containing genomic DNA from strain A909 was transformed into E. coli MC1061 and plated on LuriaBertani agar containing ampicillin (100 ,ug/ml). Colonies were transferred to nitrocellulose and lysed under chloroform as described by Helfman et al. (19) . Antisera for screening the library were raised in rabbits to mutanolysinextracted surface-associated proteins of GBS (fractions Al, and A,,,) as previously described; these antisera are protective in the mouse lethality model (27) . Second-antibody detection of expression was done with the Bio-Rad ImmunBlot goat anti-rabbit-horseradish peroxidase conjugate kit.
Preparation of antisera, SDS-PAGE, and Western immunoblots. Antisera to MC1061 containing either pJMS1, pJMS23, or pUX12 (control) were raised in rabbits by injection of sonicated whole organisms; 5 x 108 CFU of organisms were lysed by sonication and injected intravenously three times a week for 3 weeks. Alpha and beta antigen-specific polyclonal antibodies were kindly provided by Lars Bevanger, Trondheim, Norway (9) . Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting were carried out by standard techniques with a Hoeffer Mini-gel apparatus and Semi-dry transphor apparatus (27) .
IgA binding studies. Human myeloma IgA was kindly provided by Andrew Plaut and Joanne Gilbert, Boston, Mass. Bacterial extracts were run on SDS-PAGE, electroblotted onto nitrocellulose, and probed with human myeloma IgA as described previously (27) .
Mouse protection model. Lancefield's mouse lethality model of passive protection with the use of rabbit antisera was modified as described previously (25, 27) . Mice were injected intraperitoneally with 1 ml of a 1:10 dilution of rabbit serum, followed at 24 h by an intraperitoneal injection of a 90% lethal dose (LD90) of GBS (5 x 104 CFU for strain H36B, 5 x 108 CFU for strain 515) in Todd-Hewitt broth. Survivors were counted at 24 and 48 h. The survival data were analyzed by the nonparametric, exact log-rank test from StatXact (Cytel Software, Cambridge, Mass.).
RESULTS
Cloning strategy. A library of genomic DNA from GBS strain A909 (type Ia/C) was constructed in the specialized expression vectors pUX12, pUX12+1, and pUX12-1, which allow expression of inserts in all three reading frames. Briefly, GBS genomic DNA was partially digested individually with the four restriction endonucleases AluI, FnuDII, HaeIII, and RsaI because they gave fragments with a wide range of molecular weights and provided blunt ends for the addition of oligonucleotide adapters. The adapters were ligated to the partially restricted GBS DNA, which was ligated into the pUX12 vectors. The library consisted of more than 500,000 independently derived plasmids with an average GBS DNA insert size of 1.6 kb.
Screening for expression and immunoblot analysis of cloned gene products. To identify clones that express C proteins, the recombinant library of GBS DNA in pUX12 was transformed into E. coli MC1061, colonies were transferred to nitrocellulose filters, and the immunoblots were screened with protective antisera. The antisera used to screen the library were prepared in rabbits by immunization with mutanolysin-extracted surface proteins from GBS strain A909. These antisera were previously shown to provide passive immunity in a mouse lethality model and were therefore thought to contain antibodies to the C proteins (27) . Among the 20,000 colonies screened, 35 reacted with the protective antisera. The sizes of the DNA inserts for the positive clones ranged from 0.9 to 13.7 kb, with an average size of 4 Related groups of clones were identified by restriction endonuclease mapping of the inserts, DNA colony blots, and Western blot analysis with the use of the original screening antisera. Twenty-four of the 35 clones could be divided into two distinct groups, which were characterized further. The first group of 13 clones included 6 clones with an identical 13.7-kb insert that expressed a polymorphic group of proteins ranging from 40 to 116 kDa on Western blots. The distribution of sizes for these proteins is similar to the ladder pattern we observed for the native alpha antigen (27) . pJMS23 is representative of this group of clones and was chosen for further study. As shown in Fig. 1A , Western blots of extracts from pJMS23 reacted positively with three antisera, including one of the antisera used to screen the library (A,,), an alpha antigen-specific polyclonal antiserum (9) , and the alpha antigen-specific monoclonal antibody 4G8 (27) . However, extracts of the pJMS23 clone did not react with beta antigen-specific polyclonal antiserum (9) . This suggests that the clone pJMS23 expresses a protein product that is antigenically similar to the C-protein alpha antigen and that does not cross-react with antiserum to the C-protein beta antigen.
In a second group of 11 clones, 3 contained an identical 3.5-kb insert and expressed a single protein of 110 kDa on Western blots. A representative clone from this group, pJMS1, was chosen for further study. Figure 1B shows a Western blot of extracts from pJMS1 probed with one of the protective antisera used to screen the library (A,,), the beta antigen-specific polyclonal antiserum of Bevanger, and the alpha antigen monoclonal antibody 4G8. This clone bound to the beta-specific antiserum but not to the alpha antigenspecific polyclonal or monoclonal antibodies. DNA colony blot hybridization and genomic Southern blots showed that there was no cross-hybridization between the clones pJMS23 and pJMS1 (data not shown).
Protease sensitivity and immunoglobulin binding. Wilkinson and Eagon first showed that one of the C-protein antigens, now called alpha, was resistant to digestion by trypsin, whereas another C-protein antigen (beta) was sensitive to digestion by both trypsin and pepsin (39) . To determine whether the cloned gene products correlate with this protease sensitivity pattern, antisera were prepared to extracts of E. coli carrying pJMS23 and pJMS1. These antisera were used to probe mutanolysin extracts of native GBS proteins treated with either trypsin or pepsin. Figure  2A shows that native GBS proteins detected by antiserum to the clone pJMS23 were present following trypsin treatment. However, as shown in Fig. 2B , antiserum to clone pJMS1 failed to detect proteins following either trypsin or pepsin digestion of the native GBS proteins. These findings provide further support that pJMS23 and pJMS1 encode, respectively, the alpha and beta C-protein antigens of GBS.
Previous studies defining the trypsin resistance of the alpha antigen were done with immunoprecipitation with antibody to detect the antigen following trypsin treatment (8, 39) . The Western blots of the alpha antigen in Fig. 2A filustiate that although the alpha antigen is present following trypsin treatment, the overall size of this heterogeneous population of proteins is diminished. This suggests that trypsin must cleave the alpha antigen proteins at least once. However, antibody-binding sites on the alpha antigen are still present following trypsin digestion, and the protein is largely intact.
In 1984, Russell-Jones et al. (36) reported that a 130-kDa, detergent-extractable C protein binds to the Fc region of human serum IgA and secretory IgA. Figure 2C shows that human myeloma IgA immunoblotted against extracts of the clone pJMS1 identified a 110-kDa protein which corresponds to the trypsin-sensitive beta antigen. As expected, IgA did not bind to pJMS23, which encodes the alpha antigen. Cleat and Timmis have reported the cloning of a 130-kDa GBS protein that bound to IgA on immunoblots (13) .
Restriction endonuclease mapping and transposon mutagenesis of the alpha antigen clone pJMS23. As originally isolated, clone pJMS23 was 13.7 kb and contained four HindIII fragments. The structural gene for the alpha antigen was localized to a 6.0-kb HindIII fragment subcloned from pJMS23. Mutagenesis with the transposon Tn5Seql was used to define the location of the gene and infer the direction of transcription. Tn5Seql insertions were localized by restriction endonuclease mapping. The proteins expressed by the mutagenized clones were compared on Western blots probed with antiserum to pJMS23. As shown in Fig. 3 , TnSSeq insertions near the right side of the restriction map of pJMS23 abolished expression, whereas those near the left side resulted in both partial and complete gene products. These data suggest that transcription proceeds from right to left and that the structural gene is located on a 3.0-kb region within the HindIII fragment. Because transcription is in the opposite direction from that of the lacZ promoter on pUX12, the alpha antigen is expressed from a streptococcal promoter.
Restriction endonuclease mapping of pJMS23 also revealed an intragenic region with regularly repeating Styl sites yielding multiple restriction fragments of approximately 270 bp. These fragments could encode an approximately 10-kDa polypeptide. The polymorphic protein ladder seen in both the native and the cloned alpha antigen occurs at intervals of approximately 8 kDa.
Restriction endonuclease mapping and transposon mutagenesis of the beta antigen clone pJMS1. The size of the gene product encoded by pJMS1 is 110 kDa. However, the size of this beta antigen reported in the literature varies widely (7, 10, 36) . Figure 4 shows the restriction endonuclease map for the beta antigen clone pJMS1. Transposon mutagenesis with TnS showed that insertions to the right of the HindIII site did not affect the size of the gene product, as determined on Western blots. TnS insertions to the left of HindlIl abolished expression, and Tn5 insertions near the left side of pJMS1 gave smaller gene products. These results suggest that transcription proceeds from right to left and that the beta antigen gene is transcribed in E. coli from its own promoter. However, it is not clear whether pJMS1 encodes the complete C-protein beta antigen.
Analysis of cloned gene products in a mouse passive-protection model. The ability to elicit protective immunity is an important biological property of the C proteins and has served to functionally distinguish them from other surface antigens of GBS. To determine whether the cloned gene (type Ia, solid bar) strain, which does not express C proteins. The antisera to the clones protected only against the strain carrying the C proteins (H36B); antiserum to the control containing the plasmid pUX12 alone was not protective.
products of pJMS23 and pJMS1 expressed in E. coli elicit protective antibodies, antibodies to the clones were raised in rabbits and the antisera were tested in a mouse lethality model (25, 27) . The LD90 in mice was determined for GBS strains H36B (type lb/C) and 515 (type Ia). H36B carries C proteins but has a different type-specific capsule than A909, whereas 515 does not express C proteins and has a capsule type that is identical to that of A909. As shown in Fig. 5 , antisera to both pJMS23 and pJMS1 protected mice from challenge with strain H36B but not 515. These findings suggest that the antisera to the clones are protective and are specific for strains that carry the C proteins. The results are statistically significant; the differences in protection between pJMS1 and pJMS23 and the controls have P values of 0.0001 and 0.0055, respectively.
DISCUSSION
Despite advances in understanding the pathogenesis, prevention, diagnosis, and management of GBS infections, the incidence of infections, morbidity, and mortality has not changed over the past 20 years (4, 16) . GBS are classified by their type-specific polysaccharide capsule, which has a role in both virulence and immunity (34) . The role of GBS proteins in pathogenesis is less well understood. However, other streptococcal polypeptides, including the M protein of group A streptococci (17) , pneumococcal surface protein A (12) , and streptococcal toxins (37) , are thought to have an important role in virulence. The ability of the C proteins to elicit antibodies that provide passive protection in an animal model suggests that these antigenis may be important determinants in human infection. Antibodies to the C proteins have been detected in human sera in both mothers and their newborn infants (6) .
Several studies have investigated the potential roles of the C proteins in virulence. Payne and Ferrieri found that the C proteins from type II GBS may be one factor contributing to resistance to opsonization (32) . In addition, C-protein-bearing strains of GBS appear to resist intracellular killing by INFECT. IMMUN. 0 phagocytes (33) . The lack of genetic information on the C proteins has hampered studies of their role in virulence. Once the genes have been identified and described, it should be possible to create isogenic strains and to use site-directed mutagenesis to study virulence both in vitro and in vivo.
We have identified clones expressing the C-protein alpha antigens in E. coli that are biochemically and immunologically similar to the native GBS alpha antigen. The gene products of these clones bind to both polyclonal and monoclonal antibodies to the alpha antigen, antiserum to pJMS23 recognizes a trypsin-resistant native GBS surface protein, and antibodies raised to the clone are protective in an animal model. The proteins expressed by pJMS23 show a broad spectrum of molecular masses, ranging from 40 to 116 kDa, with a regularly repeating ladder at approximately 8-kDa intervals. This polymorphic population of proteins is also seen for the native alpha antigen expressed by A909 and other strains of GBS that express the alpha antigen (unpublished data). Because the same protein pattern is seen in both E. coli and GBS, it is likely that the mechanism that generates the ladder is an inherent property of the alpha antigen gene. However, it is unclear whether the heterogeneity is generated at the level of transcription or translation or by a posttranslational modification. Heterogeneity and diversity are also seen in the M protein of group A streptococci. Several genetic mechanisms have been proposed for this variability, including homologous recombination that is either intragenic (21, 24) or extragenic with gene duplication (18) .
The restriction map of pJMS23 and the sizes of the protein products are different from those of the presumptive alpha antigen clone pPHC10 reported by Cleat and Timmis (13) . They identified a single protein with a molecular mass of 190 kDa. However, in characterizing the gene products of their clone, they did not determine whether they are able to induce protective antibodies, identify whether they are trypsin resistant, or demonstrate that they correspond to the native GBS protein. The clone pPHC10 may represent either another C protein antigen or a GBS antigen that is not a C protein. The gene product of pJMS23 is also detected by a monoclonal antibody specific for the alpha antigen (27; unpublished data).
The clone pJMS1 expresses a gene product that is immunologically and biochemically similar to the native C-protein beta antigen. The gene product is a single polypeptide of 110 kDa. However, the molecular masses reported for the native GBS beta antigen range from 23,000 to several hundred thousand daltons (29) . Both the native and the cloned protein bind IgA. Antibodies to the clone pJMS1 provide passive protection in the mouse lethality model. The difference in size between the native and cloned genes may represent a truncated clone, a difference in processing of the protein, or proteolytic cleavage of the cloned gene product. Other investigators have reported smaller sizes for the beta antigen (10) . The restriction map of pJMS1 is similar to those of clones pPHC8 and pPHC33 described previously; however, the sizes of these clones differ (13) .
The C-protein beta antigen binds to the Fc receptor of IgA (36) 
